This article has been cited by
1Price and Treatment Decisions in Epidemics: A Differential Game Approach
Andrea Liddo
Mathematics.2018;6(10)190
[DOI]
2Synthesis and biological evaluation of 6-substituted-5-fluorouridine ProTides
Magdalena Slusarczyk,Salvatore Ferla,Andrea Brancale,Christopher McGuigan
Bioorganic & Medicinal Chemistry.2018;26(3)551
[DOI]
3Evolution of efficacious pangenotypic hepatitis C virus therapies
Muhammad Usman Ashraf,Kanzal Iman,Muhammad Farhan Khalid,Hafiz Muhammad Salman,Talha Shafi,Momal Rafi,Nida Javaid,Rashid Hussain,Fayyaz Ahmad,Syed Shahzad-Ul-Hussan,Shaper Mirza,Muhammad Shafiq,Samia Afzal,Sadia Hamera,Saima Anwar,Romena Qazi,Muhammad Idrees,Sohail A. Qureshi,Safee Ullah Chaudhary
Medicinal Research Reviews.2019;39(3)1091
[DOI]
4Exploration of chiral Lewis acid Mg 2+ catalysts in the synthesis of aryl organophosphate triesters from phosphorus oxychloride through a three-step, two-pot substitution sequence
Emily Granger,Katarzyna Solomianko,Cori Young,Jeremy Erb
Tetrahedron Letters.2018;59(14)1404
[DOI]
5Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses
Keivan Zandi,Leda Bassit,Franck Amblard,Bryan D. Cox,Pouya Hassandarvish,Ehsan Moghaddam,Andrew Yueh,Gisele Olinto Libanio Rodrigues,Ingredy Passos,Vivian V. Costa,Sazaly AbuBakar,Longhu Zhou,James Kohler,Mauro M. Teixeira,Raymond F. Schinazi
Antimicrobial Agents and Chemotherapy.2019;63(7)1404
[DOI]
6Effect of Sofosbuvir plus Ribavirin therapy on hepatitis C patients in Pakistan: a retrospective study
Zubia Jamil,Yasir Waheed,Maryam Malik,Asghar A. Durrani
PeerJ.2018;6(7)e4853
[DOI]
7Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients
Youssef K. Ahmad,Salwa Tawfeek,Mohamed Sharaf-Eldin,Hassan E. Elbatea,Abdelrahman Kobtan,Ferial El-Kalla,Rehab Badawi,Sherief Abd-Elsalam
Hospital Pharmacy.2017;52(4)294
[DOI]
8Roles of Fluorine in Drug Design and Drug Action
Satya Prakash Gupta
Letters in Drug Design & Discovery.2019;16(10)1089
[DOI]
9Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition
Michal Caspi Tal,Laughing Bear Torrez Dulgeroff,Lara Myers,Lamin B. Cham,Katrin D. Mayer-Barber,Andrea C. Bohrer,Ehydel Castro,Ying Ying Yiu,Cesar Lopez Angel,Ed Pham,Aaron B. Carmody,Ronald J. Messer,Eric Gars,Jens Kortmann,Maxim Markovic,Michaela Hasenkrug,Karin E. Peterson,Clayton W. Winkler,Tyson A. Woods,Paige Hansen,Sarah Galloway,Dhananjay Wagh,Benjamin J. Fram,Thai Nguyen,Daniel Corey,Raja Sab Kalluru,Niaz Banaei,Jayakumar Rajadas,Denise M. Monack,Aijaz Ahmed,Debashis Sahoo,Mark M. Davis,Jeffrey S. Glenn,Tom Adomati,Karl S. Lang,Irving L. Weissman,Kim J. Hasenkrug,Russell Vance
mBio.2020;11(3)1089
[DOI]
10Respiratory adverse effects of Sofosbuvir-based regimens for treatment of chronic hepatitis C virus
Dina Abouelkheir Abdalla,Tamer Ali Elhadidy,Tarek Besheer,Raghda Elsayed Farag
Egyptian Journal of Chest Diseases and Tuberculosis.2017;66(2)363
[DOI]
11Why Prodrugs and Propesticides Succeed
John E. Casida
Chemical Research in Toxicology.2017;30(5)1117
[DOI]
12Confronting the Multidimensional Challenges of Research in the Context of Emerging Infectious Diseases in Brazil: The Example of Yellow Fever
Vivian I. Avelino-Silva,Claudia Figueiredo-Mello,Luciana V. B. Casadio,Ana C. S. S. Nastri,Izabel Marcilio,Ana F. Ribeiro,Anna S. Levin,Ester C. Sabino
The American Journal of Tropical Medicine and Hygiene.2020;103(1)38
[DOI]
13Identification of Peptide Leads to Inhibit Hepatitis C Virus: Inhibitory Effect of Plectasin Peptide Against Hepatitis C Serine Protease
Ammar Y. Abdulrahman,Hussin A. Rothan,Nurshamimi Nor Rashid,See Khai Lim,Wajihah Sakhor,Kah Ching Tee,Teow Chong Teoh,Noorsaadah A. Rahman,Rohana Yusof
International Journal of Peptide Research and Therapeutics.2017;23(2)163
[DOI]
14Discovery of novel natural flavonoids as potent antiviral candidates against hepatitis C virus NS5B polymerase
Farideh Badichi Akher,Abdolkarim Farrokhzadeh,Pritika Ramharack,Letitia Shunmugam,Fanie R. Van Heerden,Mahmoud E.S. Soliman
Medical Hypotheses.2019;132(2)109359
[DOI]
15Blocking Zika virus vertical transmission
Pinar Mesci,Angela Macia,Spencer M. Moore,Sergey A. Shiryaev,Antonella Pinto,Chun-Teng Huang,Leon Tejwani,Isabella R. Fernandes,Nicole A. Suarez,Matthew J. Kolar,Sandro Montefusco,Scott C. Rosenberg,Roberto H. Herai,Fernanda R. Cugola,Fabiele B. Russo,Nicholas Sheets,Alan Saghatelian,Sujan Shresta,Jeremiah D. Momper,Jair L. Siqueira-Neto,Kevin D. Corbett,Patricia C. B. Beltrão-Braga,Alexey V. Terskikh,Alysson R. Muotri
Scientific Reports.2018;8(1)109359
[DOI]
16The Role of Autophagy in Interferon/Ribavirin Responders and Non-Responders with Hepatitis C Virus Infection
Fahimeh Abbasi,Taravat Bamdad,Abdolkarim Ghadimi-Moghadam,Hamzeh Chubin,Marzieh Jamalidoust
Jundishapur Journal of Microbiology.2020;13(3)109359
[DOI]
17Comparative efficacy of sofosbuvir-ribavirin versus sofosbuvir-daclatasvir for treatment of chronic hepatitis C in an area with limited NS5A inhibitor availability
Juferdy Kurniawan,Rino Alvani Gani,Irsan Hasan,Andri Sanityoso Sulaiman,Cosmas Rinaldi A. Lesmana,Chynthia Olivia Maurine Jasirwan,Kemal Fariz Kalista,Saut Horas Hatoguan Nababan,Steven Zulkifly
Indian Journal of Gastroenterology.2018;37(6)520
[DOI]
18Symmetrical Diamidates as a Class of Phosphate Prodrugs to Deliver the 5'-Monophosphate Forms of Anticancer Nucleoside Analogues
Magdalena Slusarczyk,Valentina Ferrari,Michaela Serpi,Blanka Gönczy,Jan Balzarini,Christopher McGuigan
ChemMedChem.2018;13(21)2305
[DOI]
19Kinetics and mechanism of the oxidative degradation of sofosbuvir by N-bromosuccinimide in aqueous medium
Alaa Eldin Mokhtar Abdel-Hady,Ashraf M. Taha
SN Applied Sciences.2019;1(9)2305
[DOI]
20Effects of microvirin monomers and oligomers on hepatitis C virus
Yuan-Qin Min,Xu-Chu Duan,Yi-Dan Zhou,Anna Kulinich,Wang Meng,Zhi-Peng Cai,Hong-Yu Ma,Li Liu,Xiao-Lian Zhang,Josef Voglmeir
Bioscience Reports.2017;37(3)2305
[DOI]
21The current understanding and potential therapeutic options to combat COVID-19
Venkatesh Pooladanda,Sowjanya Thatikonda,Chandraiah Godugu
Life Sciences.2020;254(3)117765
[DOI]
22The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Carolina Q. Sacramento,Gabrielle R. de Melo,Caroline S. de Freitas,Natasha Rocha,Lucas Villas Bôas Hoelz,Milene Miranda,Natalia Fintelman-Rodrigues,Andressa Marttorelli,André C. Ferreira,Giselle Barbosa-Lima,Juliana L. Abrantes,Yasmine Rangel Vieira,Mônica M. Bastos,Eduardo de Mello Volotão,Estevão Portela Nunes,Diogo A. Tschoeke,Luciana Leomil,Erick Correia Loiola,Pablo Trindade,Stevens K. Rehen,Fernando A. Bozza,Patrícia T. Bozza,Nubia Boechat,Fabiano L. Thompson,Ana M. B. de Filippis,Karin Brüning,Thiago Moreno L. Souza
Scientific Reports.2017;7(1)117765
[DOI]
23Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014–2017)
Xiaofang Zuo,Zhipeng Huo,Dongwei Kang,Gaochan Wu,Zhongxia Zhou,Xinyong Liu,Peng Zhan
Expert Opinion on Therapeutic Patents.2018;28(4)299
[DOI]
24Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
André C. Ferreira,Patrícia A. Reis,Caroline S. de Freitas,Carolina Q. Sacramento,Lucas Villas Bôas Hoelz,Mônica M. Bastos,Mayara Mattos,Natasha Rocha,Isaclaudia Gomes de Azevedo Quintanilha,Carolina da Silva Gouveia Pedrosa,Leticia Rocha Quintino Souza,Erick Correia Loiola,Pablo Trindade,Yasmine Rangel Vieira,Giselle Barbosa-Lima,Hugo C. de Castro Faria Neto,Nubia Boechat,Stevens K. Rehen,Karin Brüning,Fernando A. Bozza,Patrícia T. Bozza,Thiago Moreno L. Souza
Antimicrobial Agents and Chemotherapy.2018;63(2)e01389-18
[DOI]
25Treatment efficacy and tolerability of Sofosbuvir and Ribavirin for chronic hepatitis C infection in post renal transplant patients – A retrospective single centre study
B. Kirushnan,M.A. Shujauddin,K. Arumugam,R. Ravichandran
Indian Journal of Transplantation.2016;10(3)61
[DOI]
26Treatment efficacy and tolerability of Sofosbuvir and Ribavirin for chronic hepatitis C infection in post renal transplant patients – A retrospective single centre study
Sanaa M. Kamal
Indian Journal of Transplantation.2018;10(3)209
[DOI]
27Era of direct acting anti-viral agents for the treatment of hepatitis C
Monjur Ahmed
World Journal of Hepatology.2018;10(10)670
[DOI]
28Meta-analysis of the efficacy and safety of sofosbuvir for the treatment of hepatitis C virus infection
Hye Jin Yang,Ju Yeon Ryoo,Bong Kyu Yoo
International Journal of Clinical Pharmacy.2015;37(5)698
[DOI]
29Innovative Spectrophotometric Methods for Determination of Newly Discovered Combination for Hepatitis C Treatment
Nada S. Abdelwahab,Nehal F. Farid
Analytical Chemistry Letters.2016;6(6)783
[DOI]
30Innovative Spectrophotometric Methods for Determination of Newly Discovered Combination for Hepatitis C Treatment
Nada S. Abdelwahab,Nehal F. Farid
Analytical Chemistry Letters.2018;6(6)179
[DOI]
31Quantification of Sofosbuvir in Human Plasma: RP-HPLC Method Development and Validation
Rahul U. Rathod,K. S. Navyasree,Krishnamurthy Bhat
Pharmaceutical Chemistry Journal.2018;52(7)663
[DOI]
32Characterization of forced degradation products and in silico toxicity prediction of Sofosbuvir: A novel HCV NS5B polymerase inhibitor
Debasish Swain,Gananadhamu Samanthula,Shweta Bhagat,P.V. Bharatam,Venkatakrishna Akula,Barij N. Sinha
Journal of Pharmaceutical and Biomedical Analysis.2016;120(7)352
[DOI]
33Synthetic Approaches for the Preparation of Phosphoramidate Prodrugs of 2'-Deoxypseudoisocytidine
Michaela Serpi,Roberto De Biasi,Fabrizio Pertusati,Magdalena Slusarczyk,Christopher McGuigan
ChemistryOpen.2017;6(3)424
[DOI]
34Synthesis and antiproliferative evaluation of novel azido nucleosides and their phosphoramidate derivatives
Nuno M. Xavier,Rita Gonçalves-Pereira,Radek Jorda,Eva Reznícková,Vladimír Kryštof,M. Conceição Oliveira
Pure and Applied Chemistry.2017;89(9)1267
[DOI]
35Synthesis, Characterization and Docking Studies of Anti-HCV Molecules
Satish Kumar,P.K. Santra,J. Dwivedi,R.C. Aryan
Asian Journal of Chemistry.2020;32(5)1221
[DOI]
36Role of Interferon Gamma and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 1 Single Nucleotide Polymorphism in Natural Clearance and Treatment Response of HCV Infection
Sikandar Azam,Sobia Manzoor,Muhammad Imran,Javed Ashraf,Sarah Ashraf,Saleha Resham,Eijaz Ghani
Viral Immunology.2015;28(4)222
[DOI]
37Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2
Rudramani Pokhrel,Prem Chapagain,Jessica Siltberg-Liberles
Journal of Medical Microbiology.2020;69(6)864
[DOI]
38Stability-Indicating Method and LC–MS-MS Characterization of Forced Degradation Products of Sofosbuvir
M. Nebsen,Eman S. Elzanfaly
Journal of Chromatographic Science.2016;54(9)1631
[DOI]
39The protecting-group free selective 3'-functionalization of nucleosides
Jamie M. McCabe Dunn,Mikhail Reibarkh,Edward C. Sherer,Robert K. Orr,Rebecca T. Ruck,Bryon Simmons,Ana Bellomo
Chemical Science.2017;8(4)2804
[DOI]
40Molecular docking and statistical optimization of taurocholate-stabilized galactose anchored bilosomes for the enhancement of sofosbuvir absorption and hepatic relative targeting efficiency
Marianne Joseph Naguib,Amira Moustafa Kamel,Ahmed Thabet Negmeldin,Ahmed Hassen Elshafeey,Ibrahim Elsayed
Drug Delivery.2020;27(1)996
[DOI]
41Synthesis, biological evaluation and mode of action studies of novel amidinourea inhibitors of hepatitis C virus (HCV)
Andrea Magri,Omar Mokrane,Kate Lauder,Arvind H. Patel,Daniele Castagnolo
Bioorganic & Medicinal Chemistry Letters.2019;29(5)724
[DOI]
42Targeting GNE Myopathy: A Dual Prodrug Approach for the Delivery of N-Acetylmannosamine 6-Phosphate
Chiara Morozzi,Jana Sedláková,Michaela Serpi,Marialuce Avigliano,Rosangela Carbajo,Lucia Sandoval,Yadira Valles-Ayoub,Patrick Crutcher,Stephen Thomas,Fabrizio Pertusati
Journal of Medicinal Chemistry.2019;62(17)8178
[DOI]
43Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients
Youssef K. Ahmad,Salwa Tawfeek,Mohamed Sharaf-Eldin,Hassan E. Elbatea,Abdelrahman Kobtan,Ferial El-Kalla,Rehab Badawi,Sherief Abd-Elsalam
Hospital Pharmacy.2017;52(4)294
[DOI]
44Role of aqueous extract of saffron in ameliorating effect of sofosbuvir on the cerebellar cortex in rat
Marwa A. A. Ibrahim,Heba E. M. Sharaf Eldin,Noha R. M. Elswaidy
The Anatomical Record.2020;52(4)294
[DOI]
45Decaying relevance of clinical data towards future decisions in data-driven inpatient clinical order sets
Jonathan H. Chen,Muthuraman Alagappan,Mary K. Goldstein,Steven M. Asch,Russ B. Altman
International Journal of Medical Informatics.2017;102(4)71
[DOI]
46Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis
Hussien Ahmed,Abdelrahman I. Abushouk,Attia Attia,Mohamed Gadelkarim,Mohamed Gabr,Ahmed Negida,Mohamed M. Abdel-Daim
Journal of Infection and Public Health.2018;11(2)156
[DOI]
47Modification of N,S co-doped graphene quantum dots with p-aminothiophenol-functionalized gold nanoparticles for molecular imprint-based voltammetric determination of the antiviral drug sofosbuvir
Ashraf M. Mahmoud,Mohamed M. El-Wekil,Mater H. Mahnashi,Marwa F. B. Ali,Saad A. Alkahtani
Microchimica Acta.2019;186(9)156
[DOI]
48Novel Uridine Glycoconjugates, Derivatives of 4-Aminophenyl 1-Thioglycosides, as Potential Antiviral Compounds
Ewelina Krol,Gabriela Pastuch-Gawolek,Binay Chaubey,Gabriela Brzuska,Karol Erfurt,Boguslaw Szewczyk
Molecules.2018;23(6)1435
[DOI]
49Dynamic changes in CD45RA-Foxp3high regulatory T-cells in chronic hepatitis C patients during antiviral therapy
Zhiqin Li,Yu Ping,Zujiang Yu,Meng Wang,Dongli Yue,Zhen Zhang,Jianbin Li,Bin Zhang,Xuezhong Shi,Yi Zhang
International Journal of Infectious Diseases.2016;45(6)5
[DOI]
50Fluorinated nucleosides as an important class of anticancer and antiviral agents
Alessandra Cavaliere,Katrin C Probst,Andrew D Westwell,Magdalena Slusarczyk
Future Medicinal Chemistry.2017;9(15)1809
[DOI]
51Unexpected Response Profiles Seen in Hepatitis C Virus-Infected Patients Treated with Sofosbuvir Plus Ribavirin: Five Case Reports
Komal Saleem,Braira Wahid,Amjad Ali,Shazia Rafique,Zara Naz,Sana Usman,Muhammad Idrees
Viral Immunology.2018;31(6)480
[DOI]
52Pathways to ensure universal and affordable access to hepatitis C treatment
Caitlin H. Douglass,Alisa Pedrana,Jeffrey V. Lazarus,Ellen F. M. ‘t Hoen,Radi Hammad,Ricardo Baptista Leite,Andrew Hill,Margaret Hellard
BMC Medicine.2018;16(1)480
[DOI]
53Exploring Evolutionary Constraints in the Proteomes of Zika, Dengue, and Other Flaviviruses to Find Fitness-Critical Sites
Janelle Nunez-Castilla,Jordon Rahaman,Joseph B. Ahrens,Christian A. Balbin,Jessica Siltberg-Liberles
Journal of Molecular Evolution.2020;88(4)399
[DOI]
54Quantum molecular modeling of hepatitis C virus inhibition through non-structural protein 5B polymerase receptor binding of C 5 -arylidene rhodanines
Krishnan Balasubramanian,Vaishali M. Patil
Computational Biology and Chemistry.2018;73(4)147
[DOI]
55Novel determination of a new antiviral combination; sofosbuvir and velpatasvir by high performance thin layer chromatographic method; application to real human samples
Mamdouh R. Rezk,Hany H. Monir,Hoda M. Marzouk
Microchemical Journal.2019;146(4)828
[DOI]
56Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient
C. Taibi,M. Tempestilli,A. D'Avolio,A. R. Garbuglia,A. De Nicolò,M. Montalbano,G. D'Offizi
Journal of Clinical Pharmacy and Therapeutics.2017;42(5)621
[DOI]
57Twitter As a Noninvasive Bio-Marker for Trends in Liver Disease
Ben L. Da,Pallavi Surana,Samuel A. Schueler,Niloofar Y. Jalaly,Natasha Kamal,Sonia Taneja,Anusha Vittal,Christy L. Gilman,Theo Heller,Christopher Koh
Hepatology Communications.2019;3(9)1271
[DOI]
58Tackling SARS-CoV-2: proposed targets and repurposed drugs
Siddhi Joshi,Maithili Joshi,Mariam S Degani
Future Medicinal Chemistry.2020;3(9)1271
[DOI]
59Spectrophotometric assessment of the brand new antiviral combination: Sofosbuvir and velpatasvir in their pure forms and pharmaceutical formulation
Mamdouh R. Rezk,Hany H. Monir,Hoda M. Marzouk
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2019;213(9)159
[DOI]
60Modified nucleoside triphosphates in bacterial research for in vitro and live-cell applications
Adeline Espinasse,Hannah K. Lembke,Angela A. Cao,Erin E. Carlson
RSC Chemical Biology.2020;213(9)159
[DOI]
61Mechanism-Based Solution to the ProTide Synthesis Problem: Selective Access to Sofosbuvir, Acelarin, and INX-08189
Bryon Simmons,Zhuqing Liu,Artis Klapars,Ana Bellomo,Steven M. Silverman
Organic Letters.2017;19(9)2218
[DOI]
62Hepatitis E virus replication and interferon responses in human placental cells
Leonard Knegendorf,Svenja A. Drave,Viet Loan Dao Thi,Yannick Debing,Richard J. P. Brown,Florian W. R. Vondran,Kathrin Resner,Martina Friesland,Tanvi Khera,Michael Engelmann,Birgit Bremer,Heiner Wedemeyer,Patrick Behrendt,Johan Neyts,Thomas Pietschmann,Daniel Todt,Eike Steinmann
Hepatology Communications.2018;2(2)173
[DOI]
63Synthesis of 2'-Methyl-6-methoxyguanosine from the Parent Ribonucleoside Guanosine
Changxia Yuan,Ke Chen,Martin Eastgate
The Journal of Organic Chemistry.2019;84(8)4646
[DOI]
64CDR3 repertoire diversity of CD8+ T lymphocytes in patients with HCV
Yu Ping,Mengjia Song,Meng Wang,Zhiqin Li,Yi Zhang
Cellular Immunology.2019;336(8)34
[DOI]
65Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2
Inmaculada Sanclemente-Alaman,Lidia Moreno-Jiménez,María Soledad Benito-Martín,Alejandro Canales-Aguirre,Jordi A. Matías-Guiu,Jorge Matías-Guiu,Ulises Gómez-Pinedo
Frontiers in Immunology.2020;11(8)34
[DOI]
66Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
Caroline S. de Freitas,Luiza M. Higa,Carolina Q. Sacramento,André C. Ferreira,Patrícia A. Reis,Rodrigo Delvecchio,Fabio L. Monteiro,Giselle Barbosa-Lima,Harrison James Westgarth,Yasmine Rangel Vieira,Mayara Mattos,Natasha Rocha,Lucas Villas Bôas Hoelz,Rennan Papaleo Paes Leme,Mônica M. Bastos,Gisele Olinto L. Rodrigues,Carla Elizabeth M. Lopes,Celso Martins Queiroz-Junior,Cristiano X. Lima,Vivian V. Costa,Mauro M. Teixeira,Fernando A. Bozza,Patrícia T. Bozza,Nubia Boechat,Amilcar Tanuri,Thiago Moreno L. Souza,Samuel V. Scarpino
PLOS Neglected Tropical Diseases.2019;13(1)e0007072
[DOI]
  Feedback 
  Subscribe